About this trial

The purpose of this trial is to determine the safety and efficacy of the drug lithium and the optimum dose when used with standard chemotherapy. It will also establish how well lithium works in combination with oxaliplatin and capecitabine to treat patients with advanced oesophago-gastric or colorectal cancer. The study will also be used to learn more about this drug and this type of cancer.

Patient Profile

Advanced oesophago-gastric or colorectal cancer

Where’s this trial being run?

Cork University Hospital and St James’s Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information


Here’s a list of questions you may have for your doctor or local cancer research team.

Summary Data

Name: Lithium
Number: 11-32
Full Title:

A Phase Ib, Dose Escalation Study of Lithium When Added to Standard Chemotherapy of Oxaliplatin and Capecitabine in Patients With Advanced Oesophago-Gastric or Colorectal Cancer.

Principal Investigator:
Type: In-House

Cancer Trials Ireland

Recruitment Started: Global: Not applicable
Ireland: Nov 2019
Global Recruitment Target: Not applicable
Ireland Recruitment Target: 24